Homes for Sale in East Bay (San Francisco Bay Area)
Real Estate: Danville homes, Alameda County homes, Contra Costa County homes, Concord homes, Walnut Creek homes, Livermore, East Bay homes, Berkeley, San Ramon Danville Alamo homes, Pleasanton homes, Hayward homes, Orinda Moraga Lafayette homes, Walnut Creek Concord Pleasant Hill homes, Dublin homes, Orinda homes, Moraga homes, Lafayette homes, Antioch, Castro Valley homes, San Ramon homes, San Leandro, Pleasant Hill homes, San Lorenzo, Clayton, Alamo homes

World News   USA   Bay Area   South SF   Business   Bio Tech
Homes for Sale in East Bay (San Francisco Bay Area)
South SF, Bio Tech Timeline Monday, September 1     Author
To sell or purchase a home in South SF click here
Search Bay Area News Atlas:

Recruiters eye Genentech employees

World News
    USA (197)
        Bay Area
            South SF (121)
                Business (37)
                    Bio Tech

                        2007 (3)
                        2006 (9)
                        2005 (6)
                        2004 (4)
                        2003 (4)
                        2002 (1)

                           Genentech (26)

                        Bio Tech on Wikipedia
                        Bio Tech on Web
                        Bio Tech Books

                        Real Estate

Cell Genesys Drug Trial Halts

August 2008 ... more > Top ^

Aug. 27
  Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients
Aug. 17
  While Roche mulls whether to raise its offer price for biotechnology powerhouse, many prized Genentech professionals

April 2008 ... more > Top ^

Apr.30 Bad news on cancer drug Rituxan
  Genentech: Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder

February 2008 ... more > Top ^

Feb.22 FDA Clears Avastin for Breast Cancer
  Genentech: A Genentech drug received federal approval, a surprise decision
Feb.17 Prostate cancer vaccine shows promise  Shares in Cell Genesys shot up nearly 20% after the company released a favorable analysis of its experimental prostate cancer vaccine GVAX

January 2008 ... more > Top ^

Rogue trader to cost SocGen $7bn

year 2007 Top ^

Dec.5 FDA Panel Rejects Avastin, stock drops  Genentech: Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug Aug.3 Genentech completes Tanox acquisition  Genentech Inc. that it has completed the $919 million acquisition of its partner in the development of the asthma drug Xolair Mar.24 Genentech projects quarter to be 'flat'  Genentech expects U.S. sales in the first 3 months of the year to be essentially flat compared with the previous quarter

year 2006 Top ^

Dec.21 Genentech gets rights to drug Sep.12 Avastin approval slowed by FDA. Genentech Aug.12 Cancer drug review extended  Genentech: FDA has extended by up to 90 days its review of Herceptin for treatment of patients with breast cancer. Jul.31 Tony Blair Visits Genentech Headquarters  Heavy hitters from biotech firms sat down for an extraordinary talk with British Prime Minister Jul.11 2Q Profit Soars to $531 Million  Genentech: The biotechnology company blew past Wall Street expectations with a 79% surge in second quarter earnings Jul.1 FDA approves blindness drug  Genentech: Genentech Inc. won approval to market Lucentis, to restore sight in patients afflicted with a common eye disease Jun.29 2 drugs set to fight blindness. Genentech Feb.13 Cancer Drug Trials Scaled Back  Genentech: Avastin only targets cancer, and leaves healthy cells alone Jan.10 Genentech Best Company to Work in U.S.

year 2005 Top ^

Novartis to buy Chiron Oct.10 Big 3rd Quarter Gains. Genentech Jul.11 Profits Soar 73% in 2Q  Genentech: The second quarter profit is fueled by continued strong drug sales. The results exceeded the estimate by 4 cents Chiron Warns on Fewer Flu Vaccines Apr.16 Avastin helps those with breast cancer  Genentech: Genentech Inc.'s pioneering colon cancer is already showing potential as a lung cancer treatment Jan.10 4th best place to work for in U.S.  Genentech: Biotechnology rated fourth by Fortune

year 2004 Top ^

Nov.29 Avastin helps sickest patients  Genentech: Genentech's novel colon cancer-fighting drug helped some of the patients stay alive 2 months longer than expected VaxGen gets contract for anthrax vaccine Oct.6 Profits surge on drug sales  Genentech: Genentech reported a 52% surge in 3rd-quarter net income, fueled by strong drug sales across its product line Feb.26 FDA approves cancer fighter Avastin  Genentech: Genentech began shipping its widely anticipated colon cancer-fighting drug just hours after the government approval

year 2003 Top ^

Nov.5 Pain Therapeutics: 'abuse-resistant' pill  A biotechnology company was developing a tamper-resistant version of the painkiller OxyContin May.19 Encouraging results with cancer drug
  Genentech: Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45%
May.12 Arthritis drug fails key experiment  Genentech: The biologically engineered Raptiva failed to effectively treat patients in a key experiment AIDS vaccine developed by VaxGen

year 2002 Top ^

Sep.10 Stock plummets 9.7%  Genentech: Avastin, once-promising experimental breast cancer drug, had failed a clinical trial



Neighbor Real Estate:

Add a favorite (file a bookmark) to South SF, Bio Tech Timeline


Please send feedback to: support@mapreport.com

Advertise on South SF, Bio Tech Page